To investigate whether genome-wide association study (GWAS)-validated and GWAS-promising candidate loci influence magnetic resonance imaging measures and clinical Alzheimer's disease (AD) status.
Publication
Archives of neurology, 2010, Vol 67, Issue 6, p677